Number of Trials
The following table compares the number of open trials
categorized by sponsor types in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 10. Number of Trials By Sponsor
| Number of Open Trials* |
| Sponsor |
Total |
Median |
| National Cooperative Group |
7,185 |
120 |
| Ext. Peer Reviewed |
2,448 |
30 |
| Institutional |
4,941 |
52 |
| Industry/Pharma |
4,231 |
67 |
| Not Specified |
1,983 |
0 |
| TOTAL TRIALS* --- 20,788 |
*It is important to note that these are not
necessarily unique trials; the same trial may be open at multiple centers.
| |
|
|
Number of Patients
The following table compares the number of patients accrued
to open trials categorized by sponsor types in the 12-month reporting period
at NCI-designated Cancer Centers.
Figure 11. Patient Accrual By Sponsor
| Number of Patients Accrued |
| Sponsor |
Total |
Median |
| National Cooperative Group |
14,120 |
195 |
| Ext. Peer Reviewed |
64,398 |
206 |
| Institutional |
82,363 |
545 |
| Industry |
13,990 |
161 |
| Other/Unknown |
56,815 |
0 |
| TOTAL PATIENTS --- 231,686 |
Descriptions of the sponsor categories used above can be found on page 12 in the
summary instructions.
|
